Table 3.
Predictors for Relapse in Patients Who Receive Steroid Therapy.
| Univariable | Multivariable | ||||
|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | ||
| Age >65 years | 0.52 (0.26-1.01) | 0.053 | 0.55 (0.28-1.08) | 0.082 | |
| Male | 0.65 (0.25-1.69) | 0.380 | |||
| Diabetes | 0.61 (0.30-1.22) | 0.162 | |||
| Diffuse enlargement of pancreas | 0.93 (0.49-1.75) | 0.820 | |||
| Long or multifocal narrowing of MPD | 0.92 (0.51-1.67) | 0.787 | |||
| Serum IgG4 >270 mg/dL | 2.22 (0.92-5.34) | 0.075 | 2.41 (0.95-6.09) | 0.064 | |
| Serum IgG >1,800 | 1.14 (0.54-2.43) | 0.724 | |||
| Serum IgE >320 U/L | 2.19 (0.72-6.63) | 0.165 | |||
| Eosinophil >500/μL | 0.812 (0.29-0.30) | 0.694 | |||
| Other organ involvement | |||||
| Biliary tract | 0.48 (0.24-0.95) | 0.035 | 0.82 (0.38-1.76) | 0.604 | |
| Retroperitoneum | 1.49 (0.45-4.94) | 0.517 | |||
| Salivary gland | 1.80 (0.88-3.65) | 0.106 | |||
| Kidney | 1.99 (0.60-6.57) | 0.259 | |||
| Intravenous mPSL pulse alone | 2.90 (1.35-6.21) | 0.006 | 2.74 (1.20-6.26) | 0.016 | |
HR: hazard ratio, CI: confidence interval, DM: diabetes mellites, MPD: main pancreatic duct, mPSL: methylprednisolone